- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/335 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Lactobacillus (G)
Patent holdings for IPC class C07K 14/335
Total number of patents in this class: 171
10-year publication summary
|
6
|
5
|
8
|
12
|
14
|
8
|
13
|
18
|
11
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Florida Research Foundation, Inc. | 4035 |
8 |
| Quorum Innovations, LLC | 33 |
6 |
| Microsintesis Inc. | 12 |
6 |
| Sumitomo Chemical Company, Limited | 9043 |
4 |
| Cell Biotech Co., Ltd. | 57 |
4 |
| Intrexon ActoBiotics NV | 47 |
4 |
| Meiji Co., Ltd. | 727 |
4 |
| Centre National de La Recherche Scientifique | 10464 |
3 |
| BioGaia AB | 198 |
3 |
| The University of British Columbia | 1495 |
3 |
| Chr. Hansen A/S | 1058 |
3 |
| Agrospheres, Inc. | 40 |
3 |
| RISE Therapeutics LLC | 3 |
3 |
| Shanghai Longxin Biomedical Technology Co., Ltd | 6 |
3 |
| Massachusetts Institute of Technology | 10062 |
2 |
| Wisconsin Alumni Research Foundation | 3894 |
2 |
| The General Hospital Corporation | 4740 |
2 |
| Novozymes A/S | 3321 |
2 |
| Agency for Science, Technology and Research | 3628 |
2 |
| Bioneer Corporation | 239 |
2 |
| Other owners | 102 |